Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Novavax Inc. (NVAX) shares rose 2.71% to $7.95, outperforming competitors Johnson & Johnson, Pfizer, and Merck on a strong trading day. This marks the fifth consecutive day of gains for Novavax. The stock remains 33.58% below its 52-week high of $11.97. Trading volume reached 5.7 million, exceeding the 50-day average of 4.1 million.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) rallied 2.71% to $7.95 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.30% to 26,690.62 and the Dow Jones Industrial Average rising 0.28% to 54,036.93.
This was the stock's fifth consecutive day of gains.
Novavax Inc. closed 33.58% short of its 52-week high of $11.97, which the company achieved on February 26th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) rose 0.88% to $259.24, Pfizer Inc. (PFE) rose 2.14% to $26.76, and Merck & Co. Inc. (MRK) rose 0.16% to $128.58.
Trading volume (5.7 M) eclipsed its 50-day average volume of 4.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-07-26 1726ET